Israel Englander Moderna, Inc. Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $18.6 Million - $30.6 Million	183,900 Added 82.65%	406,400 $48.3 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $495,146 - $669,552	-5,800 Reduced 2.54%	222,500 $23.7 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $5.45 Million - $8.19 Million	78,400 Added 52.3%	228,300 $22.7 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $4.18 Million - $5.67 Million	-35,300 Reduced 19.06%	149,900 $18.2 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $6.51 Million - $9.46 Million	48,000 Added 34.99%	185,200 $28.4 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $2.23 Million - $3.95 Million	-18,800 Reduced 12.05%	137,200 $24.6 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $1.82 Million - $2.99 Million	15,400 Added 10.95%	156,000 $18.4 Million

1,027

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $20.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.